loadpatents
name:-0.035156011581421
name:-0.023943185806274
name:-0.0044140815734863
VAN DE WINKEL; Jan G. J. Patent Filings

VAN DE WINKEL; Jan G. J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for VAN DE WINKEL; Jan G. J..The latest application filed is for "human monoclonal antibodies against cd25".

Company Profile
3.20.23
  • VAN DE WINKEL; Jan G. J. - Zeist NL
  • van de Winkel; Jan G. J. - Odijk NL
  • van de Winkel, Jan G.J. - PR Odijk NL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Human Monoclonal Antibodies Against Cd25
App 20210107985 - SCHUURMAN; Janine ;   et al.
2021-04-15
Human Monoclonal Antibodies Against CD20
App 20200317799 - Teeling; Jessica ;   et al.
2020-10-08
Human monoclonal antibodies against CD25
Grant 10,703,818 - Schuurman , et al.
2020-07-07
Human Monoclonal Antibodies Against Cd25
App 20170240640 - SCHUURMAN; Janine ;   et al.
2017-08-24
Human monoclonal antibodies against CD25
Grant 9,598,493 - Schuurman , et al. March 21, 2
2017-03-21
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
Grant 9,458,236 - Van De Winkel , et al. October 4, 2
2016-10-04
Human Monoclonal Antibodies Against Cd25
App 20150259424 - SCHUURMAN; Janine ;   et al.
2015-09-17
Human monoclonal antibodies against CD25
Grant 8,961,968 - Schuurman , et al. February 24, 2
2015-02-24
Human Monoclonal Antibodies To Epidermal Growth Factor Receptor (egfr)
App 20140141006 - VAN DE WINKEL; Jan G. J. ;   et al.
2014-05-22
Human Monoclonal Antibodies Against CD20
App 20140093454 - Teeling; Jessica ;   et al.
2014-04-03
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
Grant 8,586,041 - van de Winkel , et al. November 19, 2
2013-11-19
Human monoclonal antibodies against CD20
Grant 8,529,902 - Teeling , et al. September 10, 2
2013-09-10
Human Monoclonal Antibodies Against Cd25
App 20120244069 - SCHUURMAN; Janine ;   et al.
2012-09-27
Human monoclonal antibodies against CD25
Grant 8,182,812 - Schuurman , et al. May 22, 2
2012-05-22
Human Monoclonal Antibodies To Epidermal Growth Factor Receptor (egfr)
App 20100008929 - van de Winkel; Jan G. J. ;   et al.
2010-01-14
Method for treating psoriasis by administering human antibodies specific for Interleukin 15 (IL-15)
Grant 7,597,892 - Van de Winkel , et al. October 6, 2
2009-10-06
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
Grant 7,595,378 - van de Winkel , et al. September 29, 2
2009-09-29
Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)
Grant 7,585,961 - Van De Winkel , et al. September 8, 2
2009-09-08
Human monoclonal antibodies against CD25
App 20090081219 - Schuurman; Janine ;   et al.
2009-03-26
Human monoclonal antibodies against CD25
Grant 7,438,907 - Schuurman , et al. October 21, 2
2008-10-21
Human antibodies specific for interleukin 15 (IL-15)
App 20080166802 - van de Winkel; Jan G.J. ;   et al.
2008-07-10
Human antibodies specific for interleukin 15 (IL-15)
App 20080166347 - van de Winkel; Jan G.J. ;   et al.
2008-07-10
Human antibodies specific for interleukin 15 (IL-15)
Grant 7,329,405 - van de Winkel , et al. February 12, 2
2008-02-12
Human monoclonal antibodies to FC gamma receptor II (CD32)
App 20070253958 - Van De Winkel; Jan G. J. ;   et al.
2007-11-01
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
Grant 7,247,301 - van de Winkel , et al. July 24, 2
2007-07-24
Methods of treating using anti-IL-15 antibodies
Grant 7,247,304 - van de Winkel , et al. July 24, 2
2007-07-24
Human monoclonal antibodies to FC alpha receptor (CD89)
Grant 7,192,582 - Hudson , et al. March 20, 2
2007-03-20
Human antibodies specific for interleukin 15 (IL-15)
Grant 7,153,507 - van de Winkel , et al. December 26, 2
2006-12-26
Human monoclonal antibodies against CD25
App 20040170626 - Schuurman, Janine ;   et al.
2004-09-02
Human monoclonal antibodies against CD20
App 20040167319 - Teeling, Jessica ;   et al.
2004-08-26
Methods and compositions for treating macrophage-mediated diseases
App 20040141967 - van de Winkel, Jan G.J.
2004-07-22
Human antibodies specific for interleukin 15 (IL-15)
App 20040071702 - van de Winkel, Jan G.J. ;   et al.
2004-04-15
Human antibodies specific for interleukin 15 (IL-15)
App 20030235586 - van de Winkel, Jan G.J. ;   et al.
2003-12-25
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
App 20030194403 - van de Winkel, Jan G.J. ;   et al.
2003-10-16
Human Antibodies specific for interleukin 15 (IL-15)
App 20030138421 - van de Winkel, Jan G.J. ;   et al.
2003-07-24
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
App 20030091561 - van de Winkel, Jan G.J. ;   et al.
2003-05-15
Human monoclonal antibodies to FC alpha receptor (CD89)
App 20030082643 - Hudson, Debra ;   et al.
2003-05-01
Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance Fc receptor-mediated immunotherapies
App 20030072762 - van de Winkel, Jan G. J. ;   et al.
2003-04-17
Methods for immunostimulation using binding agents for the Fc receptor of immunoglobulin A
App 20010051147 - van de Winkel, Jan G.J.
2001-12-13
Cyanidin compositions and therapeutic and diagnostic uses therefor
Grant 6,146,837 - van de Winkel November 14, 2
2000-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed